Medical News

RSS

New four-year accreditation for SCAN Health Plan's medical education program

SCAN Health Plan announced today that its continuing medical education program for physicians has received a new four-year accreditation from the Institute of Medical Quality.

6 Oct 2009

Vantia Therapeutics announces the start of Phase II proof-of-concept trials of its VA111913 drug

Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.

6 Oct 2009

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

Continuing to drive innovation in endourology, Cook Medical will feature a series of product demonstrations and interactive presentations with a special emphasis on kidney stone management solutions, including the LMA Stonebreaker and Holmium Lasers at the 27th Annual World Congress on Endourology and SWL (shock wave lithotripsy) at the Sheraton Grand Hotel in Munich, Germany from 6-10 October.

6 Oct 2009

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.

6 Oct 2009

It is possible to communicate through power of thought alone: Study

New research from the University of Southampton has demonstrated that it is possible for communication from person to person through the power of thought alone.

6 Oct 2009

Ground Zero Pharmaceuticals opens new office in Brisbane

A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.

6 Oct 2009

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.

6 Oct 2009

Mirth Corporation announces the launch of Mirth Meaningful Use Exchange

Mirth Corporation, the leader in commercial open source healthcare information technology, today announced the launch of Mirth Meaningful Use Exchange (Mirth MUx) as well as the first Mirth MUx implementation at Thayer County Health Services (TCHS).

6 Oct 2009

Hepatitis B Foundation calls for consistent monitoring and referral of HBV infected children

An expert panel of nationally recognized pediatric liver specialists convened by the Hepatitis B Foundation is calling for more consistent monitoring and referral of children chronically infected with the hepatitis B virus (HBV). The panel's recommendations for pediatricians and other primary care practitioners stress the need for routine monitoring of children with chronic HBV infections, and timely consultation with a pediatric liver specialist.

6 Oct 2009

BIOBASE to integrate its TRANSFAC database with CLC bio's popular workbenches

Today at the Biotechnica / Bio-IT World Europe conference in Hannover, Germany, BIOBASE and CLC bio announced a partnership to integrate BIOBASE's comprehensive TRANSFAC® database with CLC bio's popular workbenches and award-winning server solution.

6 Oct 2009

New line of waterproof headphones from H2O Audio

H2O Audio (www.h2oaudio.com), the leader in high performance sweatproof and waterproof headphones and accessories for active people everywhere, today unveiled three progressive new products.

6 Oct 2009

Triage NGAL Test allows early identification of AKI in ICU patients

According to a new study now available online, and to be published in an upcoming issue of the Journal of Critical Care, bedside testing for a blood biomarker called neutrophil gelatinase-associated lipocalin (NGAL) in patients being admitted to the intensive care unit can help to identify patients at risk for acute kidney injury (AKI).

6 Oct 2009

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL (“Biovail”), a subsidiary of Biovail Corporation.

6 Oct 2009

First Edition: October 6, 2009

Kathy Young, the veteran benefits administrator for a large plumbing supply company headquartered in Madison, Wis., is well versed in the often fiendish complexities of medical bills (Kaiser Health News and The Washington Post).

6 Oct 2009

HeartWare International receives approval to expand its clinical sites

HeartWare International, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the number of clinical sites participating in its U.S. bridge-to-transplant trial, known as the ADVANCE trial.

6 Oct 2009

NIMH awards SRI International a $6.3M contract for study of ligands for brain imaging research

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded a $6.3 million contract by the National Institute of Mental Health (NIMH) to conduct preclinical safety studies of promising novel ligands that will be used for brain imaging research and clinical applications.

6 Oct 2009

mtm laboratories signs additional tranche of Euro 7 million to its Series C funding

mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company’s last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in equity.

6 Oct 2009

Study finds wide disparities in advanced high school course-taking

The latest research from the Journal of Policy Analysis and Management explores the wide disparities in advanced high school course-taking (such as Advanced Placement courses) among race, poverty, and gender groups in Florida.

6 Oct 2009

ACC responds to queries regarding a study published on-line

ACC and its member companies have long-supported research to advance scientific understanding about chemicals and promote public health. To achieve these goals, that research should be based on sound scientific principles so as to be meaningful to human health. There are significant limitations in the study design, highlighted by the authors themselves, which limit the utility of the study.

6 Oct 2009

Interactive health and fitness video game

THQ Inc. today announced that The Biggest Loser interactive health and fitness video game is now available at retail outlets throughout North America exclusively for Wii™ and Nintendo DSi™/Nintendo DS™.

6 Oct 2009